Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing by Amélie Boichard, Michael J. Wagner, Razelle Kurzrock

Get full text

Therapeutic implications of cancer gene amplifications without mRNA overexpression: silence may not be golden by Amélie Boichard, Scott M. Lippman, Razelle Kurzrock

Get full text

High expression of PD-1 ligands is associated with kataegis mutational signature and APOBEC3 alterations by Amélie Boichard, Igor F. Tsigelny, Razelle Kurzrock

Get full text

The Crossroads of Precision Medicine and Therapeutic Decision-Making: Use of an Analytical Computational Platform to Predict Response to Cancer Treatments by Amélie Boichard, Stephane B. Richard, Razelle Kurzrock

Get full text

High tumor amplification burden is associated with TP53 mutations in the pan-cancer setting by Rushikesh S. Joshi, Amelie Boichard, Jacob J. Adashek, Razelle Kurzrock

Get full text

Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy by Timothy V. Pham, Amélie Boichard, Aaron Goodman, Paul Riviere, Huwate Yeerna, Pablo Tamayo, Razelle Kurzrock

Get full text

Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies by Aaron M. Goodman, Shumei Kato, Philip R. Cohen, Amélie Boichard, Garrett Frampton, Vincent Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock

Get full text

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy by Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim, Amelie Boichard, Mina Nikanjam, Elizabeth Weihe, Dennis J. Kuo, Ramez N. Eskander, Aaron Goodman, Natalie Galanina, Paul T. Fanta, Richard B. Schwab, Rebecca Shatsky, Steven C. Plaxe, Andrew Sharabi, Edward Stites, Jacob J. Adashek, Ryosuke Okamura, Suzanna Lee, Scott M. Lippman, Jason K. Sicklick, Razelle Kurzrock

Get full text